Loading...
Docetaxel and Thalidomide as a Treatment Option for Androgen- Independent, Nonmetastatic Prostate Cancer
Prostate cancer usually presents with early-stage disease, yet a significant proportion of patients present or will progress to androgen-independent, nonmetastatic prostate cancer (AIPC). Chemotherapy has demonstrated statistically significant improvements in palliation of AIPC. Docetaxel in particu...
Na minha lista:
Main Authors: | , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
MedReviews, LLC
2003
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1502338/ https://ncbi.nlm.nih.gov/pubmed/16985953 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|